Kaiser Study: Severe Obesity Boosts Risk of COVID-19 Death, Especially for the Young

August 12, 2020


A study in Annals of Internal Medicine shows severe obesity presents a greater risk of death from COVID-19 than related factors such as diabetes or hypertension.

Vaping a Risk Factor for COVID-19 in Teens, Young Adults

August 11, 2020


The authors said the findings bring new urgency to efforts by policy makers, school officials, community leaders, and others to educate the public about the link between smoking and coronavirus disease 2019 (COVID-19).

Researchers Find HRCT Risk Prediction Model Helpful in Predicting RA-ILD Prognosis

August 08, 2020


A risk prediction model based on high-resolution computed tomography (HRCT) variables outperformed other models when predicting mortality among patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).

Patients With IPF Are at Increased Risk for Multiple Cancers

August 06, 2020


Researchers found that patients with idiopathic pulmonary fibrosis (IPF) are at increased risk of developing several forms of cancer compared with the general population.

Onset of Pneumothorax Carries Poor Prognosis for Patients With CTD-ILD

July 30, 2020


According to a new study, patients with connective tissue disease-associated interstitial disease (CTD-ILD) had significantly higher mortality rates and worse 10-year survival rates than patients who did not develop the complication.

The Race to Find a COVID-19 Vaccine

July 28, 2020


The race for a coronavirus disease 2019 (COVID-19) vaccine is one of the most urgent public health challenges, with multiple vaccine candidates entering phase 3 trials and case counts around the world steadily climbing. MJH Life Sciences™ will host a free webinar with the top minds in infectious disease, virology, and vaccinology to discuss the latest trial information on vaccines.

Multidisciplinary Collaborative Care Reduces Costs, Improves End-of-Life Care for Patients With IPF

July 25, 2020


In the last 3 months of life, health care costs were significantly lower for patients receiving multidisciplinary collaborative care than for patients receiving specialized care or nonspecialized care. The differences in costs were primarily driven by differences in hospitalizations and emergency department visits.

Experimental Vaccines Show Promise Against COVID-19 in Healthy Subjects

July 21, 2020


Two experimental vaccines, one from AstraZeneca and the other from CanSino Biologics, have shown promising results against coronavirus disease 2019 (COVID-19) in a phase 1/2 trial and a phase 2 trial. Results for both were published in The Lancet.

Progressive Phenotype ILD: Effect on Personal Life

July 20, 2020


The effect of chronic fibrosing ILD with progressive phenotype on personal relationships with friends and family.